Lilly To Appeal Invalidity Ruling For Sun In Gemzar Suit
By Jocelyn Allison ( November 2, 2009, 5:42 PM EST) -- Eli Lilly & Co. is appealing a federal court ruling that invalidated one of the patents in an infringement dispute with generic-drug maker Sun Pharmaceutical Industries Ltd. over the cancer treatment Gemzar....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.